Beijing Greatsun Biomedical Technology Co., Ltd. was founded in 2011, headquartered in Zhongguancun Biomedical Technology Park, Haidian District, Beijing, China. We are committed to the discovery, development and global commercialization of innovative drugs. We only do innovative drugs that have significant clinical significance. Through the development and construction of macromolecular biotechnology platform, we try to break through and solve some diseases with clear market and clinical needs, and improve the life and quality of patients. With the help of our independently developed small molecule high-end preparation platform, we can provide new and more optimized solutions for cancer, a major disease field. In the future, we will continue to maintain the awe of life with strong research and development ability, innovation and enterprising, contribution